UOB JAIC Venture Bio Investments

UOB JAIC Venture Bio Investments is a specialized venture capital vehicle established as a joint venture between Singapore's United Overseas Bank (UOB) and Japan Asia Investment Co., Ltd. (JAIC). The firm focuses on providing equity capital and strategic support to high-growth companies within the biotechnology, pharmaceutical, and healthcare sectors. Its investment mandate historically targeted growth-stage enterprises across the Asia-Pacific region and North America, often facilitating market entry for Western companies into Asian territories. Managed by UOB JAIC Venture Management, the entity has invested in a diverse portfolio ranging from drug discovery platforms to medical device manufacturers. By leveraging the extensive regional networks and financial expertise of its parent institutions, the firm has played a significant role in funding clinical development and commercialization efforts for innovative medical technologies.